1. Hydroxyurea for primary stroke prevention in children with sickle cell anaemia in Nigeria (SPRING): a double-blind, multicentre, randomised, phase 3 trial. Issue 1 (January 2022) Authors: Abdullahi, Shehu U; Jibir, Binta W; Bello-Manga, Halima; Gambo, Safiya; Inuwa, Hauwa; Tijjani, Aliyu G; Idris, Nura; Galadanci, Aisha; Hikima, Mustapha S; Galadanci, Najibah; Borodo, Awwal; Tabari, Abdulkadir M; Haliru, Lawal; Suleiman, Aisha; Ibrahim, Jamila; Greene, Brittany C; Ghafuri, Djamila... Journal: Lancet Issue: Volume 9:Issue 1(2022) Page Start: e26 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗